神经母细胞瘤的多细胞模型提出了基于p53多重作用的非传统疗法
Kenneth Y Wertheim1,2,3,4, Robert Chisholm2, Paul Richmond2
1Insigneo Institute for in Silico Medicine, University of Sheffield, Sheffield, United Kingdom.
PLoS computational biology
|December 23, 2024
概括
我们开发了一种新的多细胞模型来模拟神经母细胞瘤瘤的生长和药物反应. 该模型揭示了有利于MYCN放大瘤的条件,并建议使用p53调制的新治疗策略.
科学领域:
- 计算机生物学和瘤学
- 儿科癌症研究儿童癌症研究
- 系统生物学 系统生物学
背景情况:
- 神经母细胞瘤是一种常见的儿科癌症,在高风险病例中预后不佳.
- 在神经母细胞瘤中,MYCN放大是至关重要的,但它的机械作用需要进一步阐明.
- 目前的治疗方法往往失败,需要新的治疗策略.
研究的目的:
- 开发和利用一个复杂的多细胞模型来模拟神经母细胞瘤动态.
- 为了研究 MYCN 增强神经母细胞瘤克隆的生长条件和药物反应.
- 根据模拟见解,确定潜在的新疗法策略.
主要方法:
- 一个多细胞模型,整合了微环境的连续自动机,具有随机行为的离散细胞代理,以及一个以中心为基础的机械模型.
- 在GPU上实施的随机模拟算法,模拟超过100万个神经母细胞瘤细胞.
- 模拟1200个异质瘤,跟踪MYCN增强克隆和测试5000种药物组合.
主要成果:
- 确定了影响瘤微环境内MYCN增强克隆生长优势的关键因素.
- 揭示了MYCN增强克隆动态,基因表达,其他瘤克隆和微环境之间的相互依赖.
- 产生的结果与现有文献一致,同时提供了新的机械洞察力.
结论:
- 提出了两种不同的神经母细胞瘤细胞群的假设,它们具有对立的p53蛋白质作用 (亲生存与亲亡).
- 建议一种新的治疗策略,包括交替抑制MDM2和ARF以调节p53活性.
- 开发的多细胞模型提供了模块化,高分辨率和可扩展性,作为患者特定数字双胞胎的基础.
更多相关视频
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.4K
12:04Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
28.8K
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K